Repatha 140 MG/ML sureclickml
Ended Awarded Last action
- Contract number
- SPE2DR26FADUL
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $43,828
Award facts
- Contract value 100% obligated
- $43,827.82 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $43,827.82 firm fixed-price delivery order to AmerSourceBergen Drug Corp on January 21, 2026, for the supply of Repatha 140 mg/ml SureClick auto-injectors. This is a non-set-aside competitive award with an ultimate completion date of January 22, 2026, and will be performed at the awardee's facility in Conshohocken, Pennsylvania. AmerSourceBergen Drug Corp, a major pharmaceutical distributor and subsidiary of Cencora, Inc., serves as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems through the DLA's Medical Supply Chain.
This delivery order is issued under AmerSourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at up to $999,999,999.00 and extending through December 2026. This comprehensive IDC vehicle enables the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs globally, including specialty medications, brand-name and generic drugs, vaccines, and medical devices across multiple therapeutic domains. Repatha is a PCSK9 inhibitor used for managing high cholesterol in patients with cardiovascular disease, representing a specialty pharmaceutical product aligned with the DLA's clinical support mission for military treatment facilities and veteran healthcare programs.
Quick answers
Who was awarded contract SPE2DR26FADUL?
SPE2DR26FADUL was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 21, 2026.
How much is contract SPE2DR26FADUL worth?
The government has obligated $43,828 on SPE2DR26FADUL.
Is contract SPE2DR26FADUL an order under another contract?
Yes. SPE2DR26FADUL is a delivery order under SPE2DR25D2011, an indefinite delivery contract.
Was contract SPE2DR26FADUL competed?
The extent of competition for SPE2DR26FADUL was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award